The cerebral mechanism of acupuncture for treating anisometropic amblyopia: a functional MRI study

注册号:

Registration number:

ITMCTR2000002939

最近更新日期:

Date of Last Refreshed on:

2020-01-27

注册时间:

Date of Registration:

2020-01-27

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

针刺干预儿童屈光参差性弱视的静息态fMRI脑功能机制研究

Public title:

The cerebral mechanism of acupuncture for treating anisometropic amblyopia: a functional MRI study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

针刺干预儿童屈光参差性弱视的静息态fMRI脑功能机制研究

Scientific title:

The cerebral mechanism of acupuncture for treating anisometropic amblyopia: a functional MRI study

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

81860879;81660816;81260560;2019-052;2019-RC-39

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000029384 ; ChiMCTR2000002939

申请注册联系人:

孙燕

研究负责人:

孙燕

Applicant:

Sun Yan

Study leader:

Sun Yan

申请注册联系人电话:

Applicant telephone:

+86 13919115910

研究负责人电话:

Study leader's telephone:

+86 13919115910

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

13919115910@163.com

研究负责人电子邮件:

Study leader's E-mail:

13919115910@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

甘肃省兰州市城关区定西东路35号

研究负责人通讯地址:

甘肃省兰州市城关区定西东路35号

Applicant address:

35 Dingxi Road East, Chengguan District, Lanzhou, Gansu, China

Study leader's address:

35 Dingxi Road East, Chengguan District, Lanzhou, Gansu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

甘肃中医药大学针灸推拿学院

Applicant's institution:

School of Acupuncture and Massage, Gansu University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

甘肃省康复中心医院医学伦理委员会

Name of the ethic committee:

Medical ethics committee of gansu rehabilitation center hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2019/3/15 0:00:00

伦理委员会联系人:

蒋雨珊

Contact Name of the ethic committee:

Jiang Yushan

伦理委员会联系地址:

甘肃省兰州市城关区定西路53号省康复中心医院

Contact Address of the ethic committee:

Provincial Rehabilitation Center Hospital, 53 Dingxi Road East, Chengguan District, Lanzhou, Gansu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

甘肃中医药大学

Primary sponsor:

Gansu University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

甘肃省兰州市城关区定西东路35号

Primary sponsor's address:

35 Dingxi Road East, Chengguan District, Lanzhou, Gansu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃中医药大学

具体地址:

城关区定西东路35号

Institution
hospital:

Gansu University of Traditional Chinese Medicine

Address:

35 Dingxi Road East, Chengguan District

经费或物资来源:

国家自然科学基金资助项目(NO.81860879;81660816;81260560);兰州市卫生健康科技发展项目医药卫生科研(2019-052); 兰州市人才创新创业项目(2019-RC-39)

Source(s) of funding:

National Natural Science Foundation (81860879;81660816;81260560); Lanzhou health science and technology development project (2019-052); Lanzhou talent innovation (2019-RC-39)

研究疾病:

弱视

研究疾病代码:

Target disease:

Amplyopia

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

本项目结合课题组的前期研究工作,紧密围绕“针刺能够有效干预和调节敏感期内弱视患儿视皮质关键区功能和结构损害及异常重组”的研究假说,拟从治疗儿童屈光性弱视的评价和机制研究入手,基于静息态fMRI技术,检测评估弱视患者视觉损害后视觉皮层功能的异常改变;在此基础上,进一步探讨和揭示针刺干预弱视的脑功能可塑性调节机制,为弱视的针灸效应研究和临床应用提供研究依据。

Objectives of Study:

This project based on previous research work, discovers closely around the acupuncture can effectively intervention and regulation of the sensitive period amblyopia in children with visual cortex area key functional and structural damage and abnormal restructuring research hypothesis, from the evaluation of treatment of refractive amblyopic children and mechanism research, this paper based on the resting state fMRI technology, testing assessment amblyopia patients abnormal changes of visual function of visual cortex after damage; On this basis, further explore and reveal the brain function plasticity regulation mechanism of acupuncture intervention on amblyopia, and provide the research basis for the acupuncture effect research and clinical application of amblyopia.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

性别不限,年龄6-12岁;屈光参差性弱视患儿;可遵医嘱完成治疗并配合完成相关指标检测者。

Inclusion criteria

No gender limitation, aged 6 to 12 years; Children with anisometropia amblyopia; Can follow the doctor's advice to complete the treatment and cooperate with the completion of relevant indicators.

排除标准:

参与本项目期间接受可能影响本项目疗效的其它疗法(包括药物疗法和其它外治法)者。

Exclusion criteria:

Other therapies (including drug therapy and other external therapies) that may affect the efficacy of the project.

研究实施时间:

Study execute time:

From 2020-01-27

To      2022-05-01

征募观察对象时间:

Recruiting time:

From 2020-01-27

To      2021-09-01

干预措施:

Interventions:

组别:

针刺组

样本量:

40

Group:

acupuncture group

Sample size:

干预措施:

针刺干预

干预措施代码:

Intervention:

acupuncture intervention

Intervention code:

组别:

对照组

样本量:

40

Group:

control group

Sample size:

干预措施:

综合治疗

干预措施代码:

Intervention:

complex treatment

Intervention code:

样本总量 Total sample size : 80

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

甘肃省

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

兰州普瑞验视光医院

单位级别:

二甲

Institution/hospital:

Lanzhou Purui Optometry Hospital

Level of the institution:

Secondary A

国家:

中国

省(直辖市):

甘肃省

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省康复中心医院

单位级别:

三甲

Institution/hospital:

Gansu Rehabilitation Center Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

光学相干断层扫描

指标类型:

主要指标

Outcome:

OCT

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

图形视觉诱发电位

指标类型:

主要指标

Outcome:

PVEP

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视力

指标类型:

次要指标

Outcome:

vision

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

静息态功能磁共振

指标类型:

主要指标

Outcome:

rs-fMRI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视功能

指标类型:

次要指标

Outcome:

visual function

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼前节检查

指标类型:

次要指标

Outcome:

Anterior nodal inspection

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 6
Min age years
最大 13
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table

盲法:

Not stated

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国临床试验注册中心 http://www.chictr.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Chinese Clinical Trial Register, http://www.chictr.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF表

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above